Picture of Quanterix logo

QTRX — Quanterix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapValue Trap

Quanterix Corp reports results for the quarter ended March 31 - Earnings Summary

Quanterix Corp QTRX.OQ reported a quarterly adjusted loss of 42 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -26 cents.  The mean expectation of six analysts for the quarter was for a loss of 44 cents per share. Wall Street expected results to range from -69 cents to -22 cents per share.

Revenue fell 5.4% to $30.33 million from a year ago; analysts expected $28.20 million.

Quanterix Corp's reported EPS for the quarter was a loss of 53 cents​.

The company reported a quarterly loss of $20.5 million.

Quanterix Corp shares had fallen by 18.9% this quarter and lost 50.3% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 32.3% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Quanterix Corp is $12.00

This summary was machine generated from LSEG data May 12 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Mar. 31 2025-0.44-0.42Beat
Dec. 31 2024-0.25-0.30Missed
Sep. 30 2024-0.24-0.22Beat
Jun. 30 2024-0.27-0.25Beat

Recent news on Quanterix

See all news